-
Values of equivalence margins and calculated 95% confidence intervals (age-tr...
Values of equivalence margins and calculated 95% confidence intervals (age-treatment-interaction) for daily weight gain, length gain, gain in head circumference as well as... -
r37980778c78--c0b76ff1eae1e4b68ddc01c5d25fb22d
Composition of intervention and control infant formula (excerpt, full details are shown in S1 Table). -
r37980778c78--171909ee9b1bb84b304fbcef2d4ea19c
Effects of the dietary glycaemic load on postprandial blood glucose and insulin response might be of importance for fat deposition and risk of obesity. We aimed to investigate... -
Patient Characteristics.
Abbreviations: AML, acute myeloid leukemia; sAML, secondary AML; ALL, acute lymphoblastic leukemia; PMF, primary myelofibrosis; CLL: chronic lymphoblastic leukemia; SAA, severe... -
Summary of adverse events.
†Total adverse events encompasses all intensities. Mild = no interference with daily activities; moderate = interferes with daily activities; severe = daily activities... -
r37980778c78--c3b4429952de0952f9ffe2c75256ecea
Baseline characteristics in the per-protocol population: Age, sex and MTHFR polymorphisms C677T (rs1801133) and A1289C (rs1801131) (data for modified intention-to-treat... -
Capillary postprandial plasma insulin, blood glucose and HbA1c and urinary c-...
Capillary postprandial plasma insulin, blood glucose and HbA1c and urinary c-peptide and urea concentrations at study end (intention-to-treat population). -
r37980778c78--1e91f17bce26f2aa064631d909efbc17
Examples of maximal expected error when using the simple formula for HSA, cross-linked with either EDC or SDA. -
Supporting data file.
Data file presenting all in vivo and ex vivo measures underlying the findings presented in this paper. (XLS) -
Folate status at Baseline and Visit 4 in the per-protocol population.
Folate status at Baseline and Visit 4 in the per-protocol population.
